[A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. ( NCI )]
UMLS (NCI) C1328134 - Pharmacologic Substance
- Immunologic Factor